Skip to main content
Equibles
CNMD logo

CNMD · CONMED Corp · Earnings Call Transcripts & Audio

Track CNMD — free

Use CNMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CNMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$46.30 +0.08 (+0.17%) At close · Sep 11
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.39B
Shares
29.95M

CONMED Corp Earnings Call Transcripts

Quarterly earnings calls for CONMED Corp (CNMD), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲10.6% $275.09M $46.15M '22 Q3 22-10-26 ▼8.4% $250.87M $26.58M '22 Q4 23-02-02 ▲21.9% $295.47M $1.82M '23 Q1 23-04-26 ▲14.6% $317.65M $13.73M '23 Q2 23-07-26 ▲10.7% $304.58M $15.84M '23 Q3 23-10-25 ▲30.4% $327.05M $33.07M '23 Q4 24-01-31 ▲5.7% $312.27M $19.71M '24 Q1 24-04-24 ▲4.5% $332.10M $29.98M '24 Q2 24-07-31 ▲4% $316.70M $48.98M '24 Q3 24-10-04 ▲5.8% $345.94M $33.75M '24 Q4 25-02-05 ▲2.9% $321.26M $6.04M '25 Q1 25-04-30 ▲3.1% $342.35M $21.42M '25 Q2 25-07-30 ▲6.7% $337.93M $2.86M '25 Q3 25-11-05 ▲7.9% $373.20M $16.74M '25 Q4 26-01-28 LATEST ▲0.3% $343.49M $23.07M '26 Q2 26-07-29
Earnings call
FY26 · Q2
2026-07-29
CONMED Corp (CNMD) Q2 2026 Earnings Call Transcript
Positive tone Orthopedic surgery results 2026 financial guidance update AirSeal insufflation platform growth
Revenue
$343.49M
▲ 0.3% YoY
Diluted EPS
$0.77
▲ 11.6% YoY
Gross margin
57.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
CONMED Corp (CNMD) Q1 2026 Earnings Call Transcript
Positive tone AirSeal Growth Platform Earnings, Interest Expense and Capital Structure GI Divestiture and Portfolio Focus
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-01-28
CONMED Corp (CNMD) Q4 2025 Earnings Call Transcript
Confident tone Q4 and full-year 2025 results International vs. US geographic mix AirSeal insufflation platform
Revenue
$373.20M*
▲ 7.9% YoY
Gross margin
58.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
CONMED Corp (CNMD) Q3 2025 Earnings Call Transcript
Positive tone General surgery platforms (AirSeal, Buffalo Filter) Orthopedics growth (BioBrace, Foot & Ankle) Tariff and margin headwinds
Revenue
$337.93M
▲ 6.7% YoY
Diluted EPS
$0.09
▼ 94.3% YoY
Gross margin
49.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
CONMED Corp (CNMD) Q2 2025 Earnings Call Transcript
Positive tone AirSeal growth platform Supply chain recovery in orthopedics/sports medicine Tariff impact
Revenue
$342.35M
▲ 3.1% YoY
Diluted EPS
$0.69
▼ 28.1% YoY
Gross margin
55.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
CONMED Corp (CNMD) Q1 2025 Earnings Call Transcript
Positive tone Tariff exposure and mitigation Full-year guidance and growth algorithm General Surgery segment and AirSeal adoption
Revenue
$321.26M
▲ 2.9% YoY
Diluted EPS
$0.19
▼ 69.8% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-05
CONMED Corp (CNMD) Q4 2024 Earnings Call Transcript
Positive tone Orthopedic supply challenges Margin and profitability improvement AirSeal growth
Revenue
$345.94M*
▲ 5.8% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-04
CONMED Corp (CNMD) Q3 2024 Earnings Call Transcript
Balanced tone CEO succession and leadership transition 2025 guidance and outlook Earnings, cash flow, and leverage performance
Revenue
$316.70M
▲ 4% YoY
Diluted EPS
$1.57
▲ 214% YoY
Gross margin
56.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
CONMED Corp (CNMD) Q2 2024 Earnings Call Transcript
Revenue
$332.10M
▲ 4.5% YoY
Diluted EPS
$0.96
▲ 123.3% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
CONMED Corp (CNMD) Q1 2024 Earnings Call Transcript
Positive tone New product launches Full year guidance Revenue growth drivers
Revenue
$312.27M
▲ 5.7% YoY
Diluted EPS
$0.63
▲ 950% YoY
Gross margin
55.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-31
CONMED Corp (CNMD) Q4 2023 Earnings Call Transcript
Confident tone AirSeal Competitive Position vs. Intuitive Orthopedics and BioBrace Capital and Single-Use Mix
Revenue
$327.05M*
▲ 30.4% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-25
CONMED Corp (CNMD) Q3 2023 Earnings Call Transcript
Revenue
$304.58M
▲ 10.7% YoY
Diluted EPS
$0.50
▼ 66.2% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
CONMED Corp (CNMD) Q2 2023 Earnings Call Transcript
Revenue
$317.65M
▲ 14.6% YoY
Diluted EPS
$0.43
Gross margin
53.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
CONMED Corp (CNMD) Q1 2023 Earnings Call Transcript
Revenue
$295.47M
▲ 21.9% YoY
Diluted EPS
$0.06
▼ 87.2% YoY
Gross margin
52.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-02
CONMED Corp (CNMD) Q4 2022 Earnings Call Transcript
Revenue
$250.87M*
▼ 8.4% YoY
Gross margin
52.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-26
CONMED Corp (CNMD) Q3 2022 Earnings Call Transcript
Revenue
$275.09M
▲ 10.6% YoY
Diluted EPS
$1.48
▲ 214.9% YoY
Gross margin
55.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
CONMED Corp (CNMD) Q2 2022 Earnings Call Transcript
Revenue
$277.19M
▲ 8.6% YoY
Diluted EPS
$-5.65
▼ 1478% YoY
Gross margin
54.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
CONMED Corp (CNMD) Q1 2022 Earnings Call Transcript
Revenue
$242.33M
▲ 4.1% YoY
Diluted EPS
$0.47
▲ 51.6% YoY
Gross margin
56.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
CONMED Corp (CNMD) Q4 2021 Earnings Call Transcript
Revenue
$273.97M*
▲ 8.4% YoY
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-27
CONMED Corp (CNMD) Q3 2021 Earnings Call Transcript
Revenue
$248.83M
▲ 4.6% YoY
Diluted EPS
$0.47
▲ 104.3% YoY
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
CONMED Corp (CNMD) Q2 2021 Earnings Call Transcript
Revenue
$255.16M
▲ 61.7% YoY
Diluted EPS
$0.41
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-28
CONMED Corp (CNMD) Q1 2021 Earnings Call Transcript
Revenue
$232.68M
▲ 8.7% YoY
Diluted EPS
$0.31
▲ 55% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-27
CONMED Corp (CNMD) Q4 2020 Earnings Call Transcript
Revenue
$252.83M
▼ 4.5% YoY
Diluted EPS
$0.81
▲ 65.3% YoY
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-28
CONMED Corp (CNMD) Q3 2020 Earnings Call Transcript
Revenue
$237.84M
▲ 1.8% YoY
Diluted EPS
$0.23
▲ 0% YoY
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-29
CONMED Corp (CNMD) Q2 2020 Earnings Call Transcript
Revenue
$157.78M
▼ 33.8% YoY
Diluted EPS
$-0.96
▼ 605.3% YoY
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
CONMED Corp (CNMD) Q1 2020 Earnings Call Transcript
Revenue
$214.01M
▼ 2% YoY
Diluted EPS
$0.20
▲ 400% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-29
CONMED Corp (CNMD) Q4 2019 Earnings Call
Revenue
$264.87M
▲ 9.2% YoY
Diluted EPS
$0.49
▼ 9.3% YoY
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 816956 CUSIP 207410101 13F (30d) 66 filings 66 filers Visit website Investor relations